STarting incrEmental Prescription of Peritoneal Dialysis
An International, Multi-centre, Randomised Controlled Trial Co-designed With Consumers With Lived Experience of Peritoneal Dialysis (PD) to Determine the Optimal Approach to Starting Patients With Kidney Failure on PD
Nábor prebieha
• bez fázy / neuvedené • intervenčná • NCT06642597
Stručný súhrn
Kidney failure is fatal without dialysis. Peritoneal dialysis (PD) completed at home offers greater flexibility and autonomy for patients . However, PD is often prescribed for 24 hours/day, 7 days/week for every patient starting dialysis. This practice is not evidence-informed, may be unnecessary and potentially harmful. The STEP-PD trial aims to determine the optimal approach to commencing patients on PD through starting at low dose PD and incrementing over time.
Základné údaje
| Ochorenia | Peritoneal Dialysis (PD), Kidney Failure |
|---|---|
| Intervencie |
OTHER: Incremental PD OTHER: Full dose PD |
| Sponzor | The University of Queensland |
| Plánovaný počet | 224 |
| Začiatok | 2025-09-19 |
| Predp. ukončenie (primárne) | 2029-09-30 |
| Krajiny | Australia, New Zealand, South Korea, Taiwan, Thailand |
| Posledná aktualizácia | 2026-06-18 |
Upozornenie: údaje sú orientačné a podliehajú zmenám. Úplné vstupné/vylučovacie
kritériá, kontakty a aktuálny stav nájdete v oficiálnom registri. Tento prehľad
nenahrádza lekársku konzultáciu.